Skip to main content

Increasing Prevalence of Chronic Diseases To Boost The Enteral Feeding Devices Market

The report "Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), by Stage (Adult, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospital, Ambulatory Care) - Global Forecast to 2021", The global enteral feeding devices market is expected to reach USD 2.80 Billion by 2021 from USD 2.15 Billion in 2016, at a CAGR of 5.5% from 2016 to 2021.

Browse 221 market data tables with 53 figures spread through 238 pages and in-depth TOC on "Enteral Feeding Devices Market by Product (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), by Stage (Adult, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospital, Ambulatory Care) - Global Forecast to 2021" 

An increasing number of hospitals and ambulatory care settings are adopting enteral nutrition as an effective method of clinical nutrition. In addition, the enteral feeding devices market is witnessing a growing adoption of technologically advanced, user-friendly safety systems that minimize complications such as misconnections, tube dislodgements, aspiration, and tube blockage. Several manufacturers in the enteral feeding devices industry are increasingly adopting patient safety techniques, such as unique connection systems to avoid misconnections of feeding tubes and user friendly features such as portable feeding pumps, programming options, programmable flushing intervals, multiple languages, occlusion pressure alarm options, history of previous feed rates, and screen and program lock-out features to prevent manipulation. Such a trend is expected to promote the greater uptake of technologically advanced enteral feeding devices in the global clinical nutrition industry. However, insufficient reimbursement in developing and underdeveloped countries and complications associated with enteral feeding tubes may restrain the growth of this market during the forecast period of 2016 to 2021.


In this report, the enteral feeding devices market is segmented based on product type, stage, end user, application, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets.

In 2015, North America accounted for the largest share of the global enteral feeding devices market, followed by Europe, Asia-Pacific, and RoW. The large share of North America and Europe in this market is primarily attributed to the development and adoption of innovative, patient-friendly enteral feeding devices integrated with safety features. Also, the presence of major companies in this region improves the accessibility of enteral feeding devices among end users. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. This is mainly attributed to the continuous efforts of Asian economies towards the development of their respective healthcare sectors. Also, the large number of preterm births in developing countries and the growing geriatric population in Japan are the other factors fueling the demand for enteral feeding devices in this region in the coming years.


The major players in the enteral feeding devices market are Fresenius SE & Co. KGaA (Germany), Halyard Health, Inc. (U.S.), Abbott Laboratories (U.S.), Covidien PLC (Ireland), B. Braun Melsungen AG (Germany), C. R. Bard, Inc. (U.S.), Cook Medical (U.S.), ConMed Corporation (U.S.), Nestlé S.A (Switzerland), and Moog, Inc. (U.S.).

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Article Credit: Healthcare DC

Comments

Popular posts from this blog

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report  " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type

Ostomy Care Accessories Market

The global ostomy care accessories market is projected to reach USD 2.99 billion by 2022 from USD 2.40 billion in 2017, at the CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of this market. The ostomy care accessories market is expected to grow at the highest CAGR during the forecast period owing to the growing skin problems due to frequent removal and re-application of skin barrier of ostomy bags and rising awareness about care of peristomal skin. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267183143 By system, the ostomy bags market is segmented into one-piece, two-piece, and skin barrier. Two-piece bags are expected to hold the

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global  cartilage regeneration market  is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i